A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

Clinical trial NCT07698899 · RECRUITING

Trial details

NCT number: NCT07698899
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Medulloblastoma Refractory Medulloblastoma CNS Metastases Central Nervous System Metastasis

Start date: 2026-07-02
Primary completion: 2030-06-02
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.